AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8594266 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/d of alpha tocopherol
Number of subjects: 22269
Study 8594266 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/d of beta carotene
Number of subjects: 22269
Study 8594266 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22269
Study 8594266 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha tocopherol plus beta carotene
Number of subjects: 22269
Study 8594266 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta carotene
Number of subjects: 22269
Study 1410953 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine intervention by a general practitioner with follow-up at three-month intervals for one year
Number of subjects: 178
Study 1410953 — intervention group
Group type: COMPARATOR
Intervention: Mini-intervention (control group) with follow-up only after 12 months
Number of subjects: 178
Study 3891813 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 5 mg
Number of subjects: 12
Study 3891813 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 10 mg
Number of subjects: 12
Study 3891813 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 15 mg
Number of subjects: 12
Study 3891813 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal dose levels of Methylphenidate
Number of subjects: 12
Study 3891813 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose and milligram-per-kilogram comparisons
Number of subjects: 12
Study 31801982 — intervention group
Group type: COMPARATOR
Intervention: Condition with a standardized breakfast used to calculate SQ (C1)
Number of subjects: 68
Study 31801982 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition with the same breakfast and ad libitum lunch and dinner buffet meals (C2)
Number of subjects: 68
Study 29661563 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Medication Management Review (HMMR) service
Number of subjects: 106
Study 29661563 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HMMR service)
Number of subjects: 106
Study 28875866 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous fumarate (FeFum)
Number of subjects: 22
Study 28875866 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium iron EDTA (NaFeEDTA)
Number of subjects: 22
Study 28875866 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of FeFum and NaFeEDTA (FeFum+NaFeEDTA)
Number of subjects: 22
Study 28875866 — intervention group
Group type: COMPARATOR
Intervention: Helicobacter pylori infection
Number of subjects: 22
Study 25840875 — intervention group
Group type: COMPARATOR
Intervention: Standard sedation (fentanyl 1 μg/kg + midazolam 0.03-0.04 mg/kg or midazolam only)
Number of subjects: 140
Study 25840875 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol Target Controlled Infusion (1.2-1.6 μg/ml)
Number of subjects: 140
Study 25840875 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol group
Number of subjects: 140
Study 23878443 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine 16 mg plus ondansetron 8 mg
Number of subjects: 100
Study 23878443 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus ondansetron 8 mg
Number of subjects: 100
Study 23878443 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine group
Number of subjects: 100
Study 23878443 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 100
Study 21266216 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) technology for detecting surgical sponges
Number of subjects: 210
Study 21266216 — intervention group
Group type: COMPARATOR
Intervention: Control (subjects served as their own controls)
Number of subjects: 210
Study 19514185 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 90
Study 19514185 — intervention group
Group type: COMPARATOR
Intervention: Drug group (Nimodipine)
Number of subjects: 90
Study 19514185 — intervention group
Group type: EXPERIMENTAL
Intervention: EA plus drug group (EA + Nimodipine)
Number of subjects: 90
Study 16778124 — intervention group
Group type: EXPERIMENTAL
Intervention: ALOX5AP gene variants (HapA, HapB)
Number of subjects: 1200
Study 16778124 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and smoking-matched participants)
Number of subjects: 1200
Study 15364709 — intervention group
Group type: EXPERIMENTAL
Intervention: docosahexaenoic acid (1200 mg/d) plus 15,000 IU/d of vitamin A (DHA + A group)
Number of subjects: 208
Study 15364709 — intervention group
Group type: COMPARATOR
Intervention: control fatty acid plus 15,000 IU/d of vitamin A (control + A group)
Number of subjects: 208
Study 15364709 — intervention group
Group type: EXPERIMENTAL
Intervention: diet rich in omega-3 fatty acids (>=0.20 g/d)
Number of subjects: 208
Study 15364709 — intervention group
Group type: EXPERIMENTAL
Intervention: duration of vitamin A supplementation prior to entry
Number of subjects: 208
Study 11206599 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ziprasidone
Number of subjects: 132
Study 11206599 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular haloperidol
Number of subjects: 132
Study 9377284 — intervention group
Group type: EXPERIMENTAL
Intervention: Optic nerve decompression surgery
Number of subjects: 305
Study 9377284 — intervention group
Group type: COMPARATOR
Intervention: Careful follow-up
Number of subjects: 305
Study 8222487 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 1028
Study 8222487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1028
Study 2869304 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of left-ventricular ejection fraction (LVEF)
Number of subjects: 60
Study 2869304 — intervention group
Group type: COMPARATOR
Intervention: Control group (no knowledge of LVEF)
Number of subjects: 60
Study 31933345 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor Cycling (IC)
Number of subjects: 48
Study 31933345 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor Cycling + Zumba (IC+ZU)
Number of subjects: 48
Study 31933345 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor Cycling + Body Pump (IC+BP)
Number of subjects: 48
Study 31933345 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 48
Study 29866304 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee (100 mg caffeine)
Number of subjects: 69
Study 29866304 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 69
Study 27322586 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-FMISO PET/CT
Number of subjects: 42
Study 27322586 — intervention group
Group type: COMPARATOR
Intervention: 18F-FETNIM PET/CT
Number of subjects: 42
Study 25171029 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous blood injection (group A, n=50)
Number of subjects: 100
Study 25171029 — intervention group
Group type: COMPARATOR
Intervention: Diluted epinephrine injection (group B, n=50)
Number of subjects: 100
Study 22822992 — intervention group
Group type: EXPERIMENTAL
Intervention: MDZ (0.02 mg/kg) followed by 0.01 mg/kg every 45 minutes + DEX (2 µg/kg/h for 10 minutes, then 0.5 µg/kg/h)
Number of subjects: 43
Study 22822992 — intervention group
Group type: EXPERIMENTAL
Intervention: MDZ (0.02 mg/kg) followed by 0.01 mg/kg every 45 minutes + DEX (1 µg/kg/h for 10 minutes, then 0.3 µg/kg/h)
Number of subjects: 43
Study 22822992 — intervention group
Group type: EXPERIMENTAL
Intervention: MDZ (0.03 mg/kg) followed by 0.01 mg/kg every 30 minutes + DEX (1 µg/kg/h for 10 minutes, then 0.3 µg/kg/h)
Number of subjects: 43
Study 22822992 — intervention group
Group type: COMPARATOR
Intervention: DEX (2 µg/kg/h for 10 minutes, then 0.5 µg/kg/h) without MDZ
Number of subjects: 43
Study 22822992 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 43
Study 20711563 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisaccade task
Number of subjects: 12
Study 20711563 — intervention group
Group type: COMPARATOR
Intervention: Saccade task
Number of subjects: 12
Study 18978162 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic capsules containing Lactobacillus rhamnosus LC705 and Propionibacterium freudenreichii ssp shermanii JS (2 x 10^10 colony forming units of each strain daily)
Number of subjects: 38
Study 18978162 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 38
Study 15795723 — intervention group
Group type: EXPERIMENTAL
Intervention: Laptop-based interactive computer program
Number of subjects: 655
Study 15795723 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 655
Study 12623916 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured abstract with low importance of results
Number of subjects: 164
Study 12623916 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured abstract with high importance of results
Number of subjects: 164
Study 12623916 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured abstract with low validity of methods
Number of subjects: 164
Study 12623916 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured abstract with high validity of methods
Number of subjects: 164
Study 10692752 — intervention group
Group type: EXPERIMENTAL
Intervention: sumatriptan suppository 6 mg
Number of subjects: 431
Study 10692752 — intervention group
Group type: EXPERIMENTAL
Intervention: sumatriptan suppository 12.5 mg
Number of subjects: 431
Study 10692752 — intervention group
Group type: EXPERIMENTAL
Intervention: sumatriptan suppository 25 mg
Number of subjects: 431
Study 8739614 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 training trials with intermodality change stimulus
Number of subjects: 128
Study 8739614 — intervention group
Group type: COMPARATOR
Intervention: 24 training trials with no-change stimulus
Number of subjects: 128
Study 8739614 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 training trials with intermodality change stimulus
Number of subjects: 128
Study 8739614 — intervention group
Group type: COMPARATOR
Intervention: 6 training trials with no-change stimulus
Number of subjects: 128
Study 1864450 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleum horwathiensis
Number of subjects: 42
Study 1864450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 6310833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine alone for 3 months followed by conversion to azathioprine and prednisolone (AP)
Number of subjects: 35
Study 6310833 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with azathioprine and prednisolone (AP)
Number of subjects: 35
Study 31752638 — intervention group
Group type: EXPERIMENTAL
Intervention: febuxostat alone
Number of subjects: 17
Study 31752638 — intervention group
Group type: EXPERIMENTAL
Intervention: febuxostat together with rasburicase
Number of subjects: 17
Study 31752638 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 17
Study 25040234 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cancer screening via mass media campaign and dental visits to a public hospital
Number of subjects: 727
Study 24435105 — intervention group
Group type: EXPERIMENTAL
Intervention: Equipment-based Pilates
Number of subjects: 86
Study 24435105 — intervention group
Group type: COMPARATOR
Intervention: Mat Pilates
Number of subjects: 86
Study 22845614 — intervention group
Group type: EXPERIMENTAL
Intervention: Apically positioned flap
Number of subjects: 30
Study 22845614 — intervention group
Group type: COMPARATOR
Intervention: Modified Widman flap
Number of subjects: 30
Study 18553116 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser protocol 1
Number of subjects: 40
Study 18553116 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser protocol 2
Number of subjects: 40
Study 17332962 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 114
Study 17332962 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 114
Study 17332962 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LC and OC)
Number of subjects: 114
Study 15383108 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned caesarean
Number of subjects: 0
Study 15383108 — intervention group
Group type: COMPARATOR
Intervention: Planned vaginal birth
Number of subjects: 0
Study 11274583 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma from multiparous donors
Number of subjects: 100
Study 11274583 — intervention group
Group type: COMPARATOR
Intervention: Control plasma
Number of subjects: 100
Study 9603093 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous DPL using an 18-gauge Veress needle
Number of subjects: 176
Study 9603093 — intervention group
Group type: COMPARATOR
Intervention: Open DPL using a standard technique
Number of subjects: 176
Study 7826960 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted bilateral salpingo-oophorectomy and vaginal hysterectomy
Number of subjects: 80
Study 7826960 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal hysterectomy and bilateral salpingo-oophorectomy
Number of subjects: 80
Study 3293828 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofantrine (1000 mg followed by 500 mg 6 hours later)
Number of subjects: 82
Study 3293828 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofantrine (500 mg every 6 hours for 3 doses)
Number of subjects: 82
Study 3293828 — intervention group
Group type: COMPARATOR
Intervention: Mefloquine (1000 mg single dose)
Number of subjects: 82
Study 3293828 — intervention group
Group type: COMPARATOR
Intervention: Mefloquine (1500 mg single dose)
Number of subjects: 82
Study 31951819 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg D-cycloserine (DCS)
Number of subjects: 38
Study 31951819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 30461578 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg)
Number of subjects: 11
Study 30461578 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 11
Study 29033015 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine pleural drainage using a 28F chest tube for 2 consecutive days (group I)
Number of subjects: 103
Study 29033015 — intervention group
Group type: COMPARATOR
Intervention: No pleural drainage (group II)
Number of subjects: 103
Study 26155952 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ultrasound treatment by CellsonicTM on one arm (30 minutes, 5 treatments)
Number of subjects: 14
Study 26155952 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no treatment)
Number of subjects: 14
Study 23188626 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with regadenoson-as-necessary (Ex-Reg, n=96)
Number of subjects: 140
Study 23188626 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole with exercise (Dip-Ex, n=44)
Number of subjects: 140
Study 23188626 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with regadenoson-as-necessary (Ex-Reg)
Number of subjects: 140
Study 23188626 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole with exercise (Dip-Ex)
Number of subjects: 140
Study 21517801 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose 5-fluorouracil 0.5%/salicylic acid 10.0% (Actikerall®)
Number of subjects: 470
Study 21517801 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 3% in hyaluronic acid (diclofenac HA)
Number of subjects: 470
Study 21517801 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 470
Study 17949894 — intervention group
Group type: EXPERIMENTAL
Intervention: F wave studies
Number of subjects: 31
Study 17949894 — intervention group
Group type: EXPERIMENTAL
Intervention: F wave parameters
Number of subjects: 31
Study 16531594 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention by firefighters (community-based intervention including a heart attack survival kit with aspirin)
Number of subjects: 20000
Study 16531594 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20000
Study 14522812 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized care in emergency departments
Number of subjects: 0
Study 14522812 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive treatment
Number of subjects: 0
Study 14522812 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense treatment for airway obstruction
Number of subjects: 0
Study 14522812 — intervention group
Group type: EXPERIMENTAL
Intervention: Current therapeutic options (ipratropium and corticosteroids with beta2 selective drugs)
Number of subjects: 0
Study 14522812 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-fatal episodes
Number of subjects: 0
Study 14522812 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical intensive care unit admissions
Number of subjects: 0
Study 10580176 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable oil based stanols (3.8 g; 2.6 g sitostanol plus 1.2 g campestanol)
Number of subjects: 112
Study 10580176 — intervention group
Group type: EXPERIMENTAL
Intervention: Pine wood based stanols (4 g; 3.7 g sitostanol plus 0.3 g campestanol)
Number of subjects: 112
Study 10580176 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 112
Study 8849849 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ketorolac tromethamine
Number of subjects: 0
Study 8849849 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1387930 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg i.v.)
Number of subjects: 220
Study 1387930 — intervention group
Group type: COMPARATOR
Intervention: Alizapride plus methylprednisolone (ALI/MPS)
Number of subjects: 220
Study 1387930 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 220
Study 6149126 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (2 mg)
Number of subjects: 7
Study 6149126 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol (2 mg)
Number of subjects: 7
Study 6149126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 3511199 — intervention group
Group type: EXPERIMENTAL
Intervention: SnF2‐polycarboxylate cement (72 mg F‐); placed in molars for 34 days (safety trial)
Number of subjects: 22
Study 3511199 — intervention group
Group type: EXPERIMENTAL
Intervention: SnF2‐polycarboxylate restoration; placed in molars during a 2 week period of no oral hygiene (efficacy trial)
Number of subjects: 22
Study 3511199 — intervention group
Group type: COMPARATOR
Intervention: Placebo restoration; placed in molars during a 2 week period of no oral hygiene (efficacy trial)
Number of subjects: 22
Study 30702226 — intervention group
Group type: EXPERIMENTAL
Intervention: Different water drinking behavior
Number of subjects: 85
Study 30702226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 26721536 — intervention group
Group type: EXPERIMENTAL
Intervention: Technician barcode scanning
Number of subjects: 2015
Study 26721536 — intervention group
Group type: COMPARATOR
Intervention: Pharmacist visual checks
Number of subjects: 2015
Study 24998012 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg with telmisartan 80 mg
Number of subjects: 60
Study 24998012 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg with rosuvastatin 20 mg
Number of subjects: 60
Study 24998012 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (rosuvastatin and telmisartan)
Number of subjects: 60
Study 24231013 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 77
Study 24231013 — intervention group
Group type: COMPARATOR
Intervention: Traditional total parenteral nutrition
Number of subjects: 77
Study 19669690 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical excision of the lesion
Number of subjects: 2
Study 18923572 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginseng (1125 mg.d‐1)
Number of subjects: 10
Study 16374152 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (50 mg hydrocortisone every 6 hrs and 50 microg of 9-alpha-fludrocortisone once a day for 7 days)
Number of subjects: 300
Study 16374152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 16374152 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 300
Study 14609804 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (1 mg to 3 mg/day)
Number of subjects: 175
Study 14609804 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg to 20 mg/day)
Number of subjects: 175
Study 10338105 — intervention group
Group type: EXPERIMENTAL
Intervention: 12g piracetam daily for 4 weeks and maintenance treatment for a further 8 weeks
Number of subjects: 927
Study 10338105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 927
Study 8704693 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone and cyclosporin A (CsA)
Number of subjects: 9
Study 1792797 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol 400 mg daily
Number of subjects: 26
Study 1792797 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with prolactin antagonist and progesterone
Number of subjects: 26
Study 6342126 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (12 patients) - antibiotics stopped for 18 months
Number of subjects: 23
Study 6342126 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (11 patients) - received antibiotics when necessary for 18 months
Number of subjects: 23
Study 31028826 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography
Number of subjects: 79
Study 31028826 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 79
Study 30085149 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine co-administered with chloroquine
Number of subjects: 49
Study 30085149 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine co-administered with dihydroartemisinin/piperaquine
Number of subjects: 49
Study 30085149 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine co-administered with pyronaridine/artesunate
Number of subjects: 49
Study 30085149 — intervention group
Group type: COMPARATOR
Intervention: Primaquine alone
Number of subjects: 49
Study 27212774 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 70
Study 27212774 — intervention group
Group type: COMPARATOR
Intervention: 2% lignocaine
Number of subjects: 70
Study 24972254 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillation (HFO)
Number of subjects: 319